Rossari Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

11.07

11.05

11.03

11.01

10.39

Share application money

-

3.68

-

3.29

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1,066.10

945.61

847.67

770.23

394.06

Loan funds

Secured loans

30.14

55.05

64.92

-

-

Unsecured loans

-

-

-

-

-

Total

1,107.32

1,015.39

923.61

784.52

404.44

Uses of funds

Fixed assets

Gross block

317.27

279.16

247.35

245.92

216.53

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

138.06

111.87

91.92

68.55

45.78

Net block

179.20

167.29

155.44

177.38

170.75

Capital work-in-progress

34.09

24.60

13.68

0.84

0.32

Investments

538.39

528.16

493.09

380.86

9.25

Net current assets

Current assets, loans & advances

699.24

561.12

463.47

366.86

364.03

Less : current liabilities & provisions

343.60

265.78

202.06

141.41

139.92

Total net current assets

355.63

295.34

261.41

225.45

224.12

Miscellaneous expenses not written

-

-

-

-

-

Total

1,107.32

1,015.39

923.61

784.52

404.44

Notes:

Book value of unquoted investments

493.11

490.60

472.78

380.86

9.25

Market value of quoted investments

45.29

37.56

20.31

9.01

-

Contingent liabilities

236.48

94.11

125.56

178.26

5.13

Number of equity sharesoutstanding (Lacs)

553.64

552.46

551.55

550.56

519.29